Complementary and alternative medicine in hepatology: review of the evidence of efficacy.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Clinical Gastroenterology and Hepatology

• Publication date

  2007-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CGH.2006.10.014PMID 17222587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibitory effect of glycyrrhizin on NF-kappaB binding activity in CCl4- plus ethanol-induced liver cirrhosis in rats.

  2008cited by this paper
• S-adenosyl-L-methionine for alcoholic liver diseases.

  2006cited by this paper
• Oral silymarin for chronic hepatitis C - a retrospective analysis comparing three dose regimens.

  2005cited by this paper
• Milk Thistle for Alcoholic and/or Hepatitis B or C Liver Diseases—A Systematic Cochrane Hepato-Biliary Group Review with Meta-Analyses of Randomized Clinical Trials

  2005cited by this paper
• Use of herbal supplements for chronic liver disease.

  2004cited by this paper
• Initial experience with ribavirin plus glycyrrhizin in renal allograft recipients with chronic hepatitis C.

  2004cited by this paper
• Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results.

  2004cited by this paper
• Double‐blinded placebo‐controlled study of Phyllanthus urinaris for the treatment of chronic hepatitis B

  2003cited by this paper
• Randomized clinical trial with two doses (100 and 40 ml) of Stronger Neo-Minophagen C in Chinese patients with chronic hepatitis B.

  2002cited by this paper
• Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study.

  2002cited by this paper
• Use of complementary and alternative medicine in patients with liver disease

  2002cited by this paper
• Complementary and alternative medicine in chronic liver disease

  2001cited by this paper
• A trial of a Chinese herbal medicine for chronic hepatitis C

  2001cited by this paper
• Pharmacokinetics, Safety, and Antiviral Effects of Hypericin, a Derivative of St. John's Wort Plant, in Patients with Chronic Hepatitis C Virus Infection

  2001cited by this paper
• Herbal medicines consumption for chronic liver disease and functional intestinal disorders: Prospective study in 526 outpatients

  2001cited by this paper
• A randomized double blind, placebo controlled trial of a Chinese herbal preparation (CH100) in chronic hepatitis C.

  2001cited by this paper
• Herbal and complementary and alternative medicine therapies for liver disease. A focus on Chinese traditional medicine in hepatitis C virus.

  2001cited by this paper
• Genus Phyllanthus for chronic hepatitis B virus infection: a systematic review

  2001cited by this paper
• Glycyrrhizin-induced reduction of alt in european patients with chronic hepatitis C

  2001cited by this paper
• St John's wort: Prozac from the plant kingdom.

  2001cited by this paper
• 23 Complementary and alternative medicine in hepatitis C

  2000cited by this paper
• Silymarin: What is in the name …? An appeal for a change of editorial policy

  2000cited by this paper
• Transmission of hepatitis C virus in Asia: past and present perspectives

  2000cited by this paper
• Consumer Use of St. John's Wort: A Survey on Effectiveness, Safety, and Tolerability

  2000cited by this paper
• Treatment of chronic liver diseases with traditional Chinese medicine

  2000cited by this paper
• [Proliferation and apoptosis of hepatic stellate cells and effects of compound 861 on liver fibrosis].

  2000cited by this paper
• Acute heart transplant rejection due to Saint John's wort.

  2000cited by this paper
• Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation.

  2000cited by this paper
• Effects of CH-100, a chinese herbal medicine, on acute concanavalin A-mediated hepatitis in control and alcohol-fed rats.

  2000cited by this paper
• Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.

  2000cited by this paper
• Drug Interaction between St. John's Wort and Cyclosporine

  2000cited by this paper
• Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

  2000cited by this paper
• Silybum marianum (milk thistle).

  1999cited by this paper
• Treatment with glutathione precursor decreases cytokine activity.

  1999cited by this paper
• Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients.

  1999cited by this paper
• Effects of acupuncture on the immunological functions in hepatitis B virus carriers.

  1999cited by this paper
• S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

  1999cited by this paper
• Herbal products for liver diseases: A therapeutic challenge for the new millennium

  1999cited by this paper
• Hepatoprotective effects of Liv-52 on ethanol induced liver damage in rats.

  1999cited by this paper
• Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection.

  1999cited by this paper
• Effects of sho‐saiko‐to, a japanese herbal medicine, on hepatic fibrosis in rats

  1999cited by this paper
• Oxidative stress as a mechanism of chronic cadmium-induced hepatotoxicity and renal toxicity and protection by antioxidants.

  1999cited by this paper
• Is there any use for nontraditional or alternative therapies in patients with chronic liver disease?

  1999cited by this paper
• [Inhibitory effect of glycyrrhizin on NF-kappa B binding activity in CCl4 plus ethanol induced liver cirrhosis in rats].

  1999cited by this paper
• [Autoimmune hepatitis with drug-induced pneumonia due to Sho-saiko-to].

  1999cited by this paper
• Liver enzyme elevations in patients treated with traditional Chinese medicine.

  1999cited by this paper
• A conservative triple antioxidant approach to the treatment of hepatitis C

  1999cited by this paper
• Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions.

  1998cited by this paper
• LIVER INJURY FROM HERBS AND OTHER BOTANICALS

  1998cited by this paper
• S-adenosylmethionine deficiency and TNF-alpha in lipopolysaccharide-induced hepatic injury.

  1998cited by this paper
• Preliminary report of a randomized, double‐blind placebo‐controlled trial of a Chinese herbal medicine preparation CH‐100 in the treatment of chronic hepatitis C

  1998cited by this paper
• Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

  1998cited by this paper
• Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model.

  1998cited by this paper
• Alterations are ahead at the OAM. Office of Alternative Medicine.

  1998cited by this paper
• Milk Thistle (Silybum marianum) for the Therapy of Liver Disease

  1998cited by this paper
• Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

  1998cited by this paper
• Alterations Are Ahead at the OAM

  1998cited by this paper
• Hepatitis C

  1998cited by this paper
• Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors

  1997cited by this paper
• The Ayurvedic drug LIV.52 in patients with alcoholic cirrhosis. Results of a prospective, randomized, double-blind, placebo-controlled clinical trial

  1997cited by this paper
• The long term efficacy of glycyrrhizin in chronic hepatitis C patients

  1997cited by this paper
• Autoimmune hepatitis triggered by administration of an herbal medicine.

  1997cited by this paper
• Effects of silibinin and of a synthetic analogue on isolated rat hepatic stellate cells and myofibroblasts.

  1997cited by this paper
• Antiviral activity of aucubin against hepatitis B virus replication

  1997cited by this paper
• Traditional Remedies and Food Supplements

  1997cited by this paper
• Effects of glycyrrhizin on immune‐mediated cytotoxicity

  1997cited by this paper
• Oxygen‐free radical‐mediated injury to cultured rat hepatocytes during cold incubation in preservation solutions

  1997cited by this paper
• Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats

  1997cited by this paper
• Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin

  1996cited by this paper
• The U.S. botanical market - an overview

  1996cited by this paper
• Cell Death Induced by Baicalein in Human Hepatocellular Carcinoma Cell Lines

  1996cited by this paper
• St John's wort for depression—an overview and meta-analysis of randomised clinical trials

  1996cited by this paper
• The use of naturopathic remedies for chronic liver disease.

  1996cited by this paper
• Hepatitis induced by traditional Chinese herbs; possible toxic components.

  1995cited by this paper
• [A possible mechanism of interstitial pneumonia during interferon therapy with sho-saiko-to].

  1995cited by this paper
• Liver injuries induced by herbal medicine, Syo-saiko-to (xiao-chai-hu-tang)

  1995cited by this paper
• Antioxidant activity of silybin in vivo during long-term iron overload in rats.

  1995cited by this paper
• Prospective study of chemoprevention of hepatocellular carcinoma with sho‐saiko‐to (TJ‐9)

  1995cited by this paper
• Liver Injuries Induced by Herbal Medicine, Sho-saiko-to (xiao-chai-hu-tang)

  1995cited by this paper
• Failure of New Zealand hepatitis B carriers to respond to Phyllanthus amarus.

  1994cited by this paper
• The effect of silymarin on plasma levels of malon-dialdehyde in patients receiving long-term treatment with psychotropic drugs

  1994cited by this paper
• Scavenging of reactive oxygen species by silibinin dihemisuccinate.

  1994cited by this paper
• [Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C].

  1994cited by this paper
• Hepato protective effect of Liv-52 against CCl4 induced lipid peroxidation in liver of rats.

  1994cited by this paper
• Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study.

  1994cited by this paper
• Combined traditional Chinese medicine and Western medicine. Relieving effects of Chinese herbs, ear-acupuncture and epidural morphine on postoperative pain in liver cancer.

  1994cited by this paper
• Effect of an extract from Phyllanthus amarus on hepatitis B surface antigen gene expression in human hepatoma cells.

  1993cited by this paper
• Unconventional medicine in the United States. Prevalence, costs, and patterns of use.

  1993cited by this paper
• Hepatitis after Germander (Teucrium chamaedrys) Administration: Another Instance of Herbal Medicine Hepatotoxicity

  1992cited by this paper
• Effect of sho-saiko-to(xiao-chai-hu-tang) on HBeAg clearance in children with chronic hepatitis B virus infection and with sustained liver disease.

  1991cited by this paper
• Glycyrrhizin withdrawal followed by human lymphoblastoid interferon in the treatment of chronic hepatitis B

  1991cited by this paper
• Efficacy of Phyllanthus amarus for eradication of hepatitis B virus in chronic carriers.

  1991cited by this paper
• Beneficial effects of Phyllanthus amarus for chronic hepatitis B, not confirmed.

  1991cited by this paper
• Effects of TJ-9 Sho-saiko-to (kampo medicine) on interferon gamma and antibody production specific for hepatitis B virus antigen in patients with type B chronic hepatitis.

  1991cited by this paper
• Failure of Phyllanthus amarus to eradicate hepatitis B surface antigen from symptomless carriers.

  1990cited by this paper
• Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects

  1990cited by this paper
• [Suppression of lipid peroxidation by sho-saiko-to and its components in rat liver subcellular membranes].

  1990cited by this paper
• A multicenter randomized controlled clinical trial of Shosaiko-to in chronic active hepatitis

  1989cited by this paper
• Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver.

  1989cited by this paper
• Silybin Dihemisuccinate Protects Against Glutathione Depletion and Lipid Peroxidation Induced by Acetaminophen on Rat Liver

  1989cited by this paper

• Prevalence and outcome of children with acute viral hepatitis using complementary and alternative medications (CAM) presenting to a tertiary care center of North India: A Prospective Observational Study

  2026cites this paper
• Prevalence and patterns of complementary and alternative medicine use in patients with chronic liver disease

  2025cites this paper
• Supplementation with Silybum marianum Extract, Synbiotics, Omega-3 Fatty Acids, Vitamins, and Minerals: Impact on Biochemical Markers and Fecal Microbiome in Overweight Dogs

  2024cites this paper
• When views about alternative medicine, nature and god come in the way of people's vaccination intentions

  2024cites this paper
• Preclinical Evaluation of the effect of Pijusballi Rasa (PLRM) on steroidal and gonadotropin hormone profile on chronic administration to the male Sprague-Dawley rats

  2024cites this paper
• Use of Complementary and Alternative Medicine in Patients with Autoimmune Bullous Dermatoses: A Cohort Study Analysis of a Rare Disease Group

  2023cites this paper
• New Insights into Herb-Induced Liver Injury

  2022cites this paper
• How is the behavioral immune system related to hygiene behaviors?

  2022cites this paper
• Herbal and dietary supplements hepatotoxicity: Prevalence, Epidemiology and Key Issues

  2022cites this paper
• Secular Trends in Severe Idiosyncratic Drug-Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry

  2022cites this paper
• Pediatric acute viral hepatitis with atypical variants: Clinical dilemmas and natural history

  2022cites this paper
• Hepatoprotective and therapeutic effects of resveratrol: A focus on anti‐inflammatory and antioxidative activities

  2021cites this paper
• The protective effect of cannabinoid type II receptor agonist AM1241 on ConA-induced liver injury in mice via mitogen-activated protein kinase signalling pathway

  2021cites this paper
• A narrative review of herb-induced liver injury

  2021cites this paper
• Tetrazole exerts anti-hepatitis effect in mice via activation of PI3K/Akt pathway, inhibition of cell autophagy and suppression of inflammatory cytokine expressions

  2021cites this paper
• Evaluation of Cytotoxic Activity of Lavandula stoechas Aerial Parts Fractions against HepG2 Cell Lines

  2020cites this paper
• The Hepatoprotective Effect of Taurisolo, a Nutraceutical Enriched in Resveratrol and Polyphenols, Involves Activation of Mitochondrial Metabolism in Mice Liver

  2020cites this paper
• TOWARD NONALCOHOLIC FATTY LIVER TREATMENT; A REVIEW ON HERBAL MEDICINE TREATMENT

  2020cites this paper
• Hepatitis

  2020cites this paper
• Hepatotoxicological Studies of an Ayurvedic Medicine “Brihat Khadir Batika” on Biological System of Male Sprague–Dawley Rats

  2020cites this paper
• Diet-related Improvement of Non-Alcoholic Fatty Liver Based on Iranian Traditional Medicine (Persian Medicine): Case Report

  2020cites this paper
• Profile of herbal and dietary supplements induced liver injury in Latin America: A systematic review of published reports

  2020cites this paper
• Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B.

  2019cites this paper
• Toxicology and Drug Interactions of Nutraceuticals

  2019cites this paper
• Histological Investigation of the Hepatic Tissue in Mice Induced by Soft Laser with Different Doses

  2019cites this paper
• COMPLEMENTARY AND ALTERNATIVE MEDICINE

  2019cites this paper
• Herbal and Dietary Supplement‐Induced Liver Injuries in the Spanish DILI Registry

  2018cites this paper
• Baicalein Enhances the Oral Bioavailability and Hepatoprotective Effects of Silybin Through the Inhibition of Efflux Transporters BCRP and MRP2

  2018cites this paper
• The milk thistle (Silybum marianum) compound Silibinin stimulates leukopoiesis from mouse embryonic stem cells

  2018cites this paper
• Chinese Herbal Medicine Combined with Entecavir for HBeAg Positive Chronic Hepatitis B: Study Protocol for a Multi-Center, Double-Blind Randomized-Controlled Trial

  2018cites this paper
• Investigating owner use of dietary supplements in dogs with idiopathic epilepsy.

  2018cites this paper
• Potential of Aucklandia Lappa Decne Ethanolic Extract to Trigger Apoptosis of Human T47D and Hela Cells

  2018cites this paper
• THE RECOMMENDED IRANIAN TRADITIONAL MEDICINE (PERSIAN MEDICINE) DIET IN NON- ALCOHOLIC FATTY LIVER DISEASE

  2017cites this paper
• Hepatotoxicity of Herbal Supplements Mediated by Modulation of Cytochrome P450

  2017cites this paper
• Ayurvedic drug induced liver injury

  2017cites this paper
• High Dose of Silymarin in Patients with Decompensated Liver Disease: A Randomized Controlled Trial

  2017cites this paper
• Nutrigenomic activity of plant derived compounds in health and disease: Results of a dietary intervention study in dog.

  2016cites this paper
• Effect of Aqueous Leaf Extract of Ocimum gratissimum on Antiretroviral Drug-Induced Hepatotoxicity in Rats

  2016cites this paper
• Complementary and Alternative Medicine

  2016cites this paper
• Complementary and alternative medicine

  2016cites this paper
• Experimental Study of the Role of Soft Laser in the Production of Probable Histological Alterations in the Architecture of Mouse Hepatocyte

  2015cites this paper
• Manic episode with psychotic features induced by a herbalife production (Herbalife ürünün tetiklediği psikotik özellikli manik atak)

  2015cites this paper
• Evidence chain-based causality identification in herb-induced liver injury: exemplification of a well-known liver-restorative herb Polygonum multiflorum

  2015cites this paper
• Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences

  2015cites this paper
• Protective Effects of N-Acetylcysteine in Concanavalin A-Induced Hepatitis in Mice

  2015cites this paper
• Emodin Protects Against Concanavalin A-Induced Hepatitis in Mice Through Inhibiting Activation of the p38 MAPK-NF-κB Signaling Pathway

  2015cites this paper
• Effects of Silymarin on blood parameters of broilers in an experimental chronic mycotoxicosis

  2015cites this paper
• Herbal and dietary supplement hepatotoxicity

  2014cites this paper
• Reactive Oxygen Species (ROS) and Liver Disease Therapy

  2014cites this paper
• Probing herb induced liver injury (HILI) using population data and computational phyto-analysis

  2014cites this paper
• Ocimum gratissimum is effective in prevention against liver fibrosis in vivo and in vitro.

  2014cites this paper
• Hepatoprotective and Antioxidant Activities of Hepacare®, a Herbal Formulation Against Carbon Tetrachloride-Induced Liver Injury

  2014cites this paper
• The Clinical Outcome of the Extract of Ginkgo biloba in Egyptian Chronic Hepatitis C Patients .

  2014cites this paper
• Cigna Medical Coverage Policy Subject Complementary and Alternative Medicine

  2014cites this paper
• Liver abnormalities in drug and substance abusers.

  2013cites this paper
• Hepatoprotective role of Abelmoschus esculentus (Linn.) Moench., on carbon tetrachloride-induced liver injury

  2013cites this paper
• Anti-hepatitis B virus lignans from the root of Streblus asper.

  2013cites this paper
• Silimarina, ácido alfa-lipoico y seleniometionina en el tratamiento de hígado graso: revisión sistemática de la literatura

  2013cites this paper
• The use of complementary and alternative therapies and of psychotherapy by Romanian patients with irritable bowel syndrome.

  2013cites this paper
• Review article: herbal and dietary supplement hepatotoxicity

  2013influential citation
• Curcumin Protects Against Concanavalin A-Induced Hepatitis in Mice Through Inhibiting the Cytoplasmic Translocation and Expression of High Mobility Group Box 1

  2012cites this paper
• Role of the 5-HT1A Serotonergic System in Anxiolytic-Like Effects of Silymarin

  2012cites this paper
• Anti-hepatitis B virus constituents from the stem bark of Streblus asper.

  2012cites this paper
• Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial.

  2012cites this paper
• Polyprenols from Taxus chinensis var. mairei prevent the development of CCl₄-induced liver fibrosis in rats.

  2012cites this paper
• [Hepatotropic medicines: current status].

  2012cites this paper
• Anti-HBV activities of Streblus asper and constituents of its roots.

  2012cites this paper
• Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

  2012cites this paper
• Role of Serotonergic System on Modulation of Depressogenic-Like Effects of Silymarine

  2012cites this paper
• The effect of iron on hepatitis C virus replication

  2011cites this paper
• Silymarin use and liver disease progression in the Hepatitis C Antiviral Long‐Term Treatment against Cirrhosis trial

  2011cites this paper
• Complementary and Alternative Medicine

  2011cites this paper
• Activity of essential phospholipids (EPL) from soybean in liver diseases

  2011cites this paper
• "The Chinese Phytotherapy: Oriental and Western Pathophysiological Aspects and Perpectives - The Example of Ephedrae Decotum".

  2011cites this paper
• In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines.

  2011cites this paper
• Complementary and Alternative Medicine

  2010cites this paper
• The use of complementary and alternative medicine by patients with chronic hepatitis C.

  2010cites this paper
• Malnutrition and Nutrition in Liver Disease

  2010cites this paper
• Liver Disease Caused by Anesthetics, Toxins, and Herbal Preparations

  2010cites this paper
• "Do you want a vodka? No, a green tea please!" Epigallocatechin gallate and its possible role in oxidative stress and liver damage.

  2009cites this paper
• Use of Alternative Medicine for Chronic Hepatitis C-A Hospital BasedStudy from Rawalpindi -

  2009cites this paper
• Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies

  2009cites this paper
• Effects of resveratrol pretreatment on tert-butylhydroperoxide induced hepatocyte toxicity in immobilized perifused hepatocytes: involvement of inducible nitric oxide synthase and hemoxygenase-1.

  2009cites this paper
• Herbal and Non-Traditional Therapies for Viral Hepatitis

  2009influential citation
• Therapeutic use of cytoprotective agents in canine and feline hepatobiliary disease.

  2009cites this paper
• Ethnic Variations in Chronic Liver Diseases

  2008cites this paper
• Complementary and alternative medicine.

  2008cites this paper
• Hepatitis C

  2008cites this paper
• Complementary and alternative medicines for hepatic disease.

  2008cites this paper
• Antioxidants in the treatment of chronic liver diseases: Why is the efficacy evidence so weak in humans?

  2008cites this paper
• Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy.

  2008cites this paper
• Black cohosh, safety, and public awareness

  2007cites this paper
• Herbal product use by persons enrolled in the hepatitis C Antiviral Long‐Term Treatment Against Cirrhosis (HALT‐C) Trial

  2007cites this paper
• Advances in the Use of Milk Thistle (Silybum marianum)

  2007cites this paper
• HEPATITIS B VIRUS SCREENING AND COUNSELING STRATEGIES FOR GENERAL PRACTITIONERS

  2007influential citation
• Статины в профилактике и лечении связанных с атеросклерозом заболеваний: эффективность и безопасность

  2005cites this paper